Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies—Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce
Clinical and Translational Allergy · 2023-06 · 13 (6)
DOI: 10.1002/clt2.12250 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Allergy, online erschienen am 02.06.2023. Verfasst von Julijana Asllani und 20 weiteren Autor:innen. Beteiligte Einrichtung: University of Medicine, Tirana, Albania. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stallergenes, European Academy of Allergy and Clinical Immunology.
Themen: Patientensicherheit, Kinderkrankenpflege
Abstract (Originalsprache)
Background
Although it has been shown that allergen immunotherapy (AIT) is well‐tolerated in children, systematic and prospective surveillance of AIT safety in real life settings is needed.
Methods
The multinational Allergen Immunotherapy Adverse Events Registry (ADER) was designed to address AIT safety in real life clinical practice. Data on children ≤18 years old with respiratory allergies undergoing AIT were retrieved. Patient‐ and AIT‐related features were collected and analyzed. The characteristics of adverse events (AE) and risk factors were evaluated.
Results
A total of 851 patients, 11.3 ± 3.4 years old, with rhinitis only (47.6%); asthma and rhinitis (44.5%); asthma (7.9%), receiving 998 AIT courses were analyzed. Sublingual immunotherapy (SLIT) accounted for 51% of the courses. In 84.5% of patients only one AIT treatment was prescribed. Pollen was the most frequent sensitizer (57.1%), followed by mites (53.4%), molds (18.2%) and epithelia (16.7%). Local and systemic AEs were reported in 85 patients (9.9%). Most AEs (83.1%) were mild and occurred in
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Medicine, Tirana, Albania.
- Allergy and Asthma Medical Clinic, Tirana, Albania.
- Allergy Department 2nd Pediatric Clinic, University of Athens, Athens, Greece.
- Department of Allergy and Clinical Immunology, 424 General Military Training Hospital, Thessaloniki, Greece.
- University Hospital Center "Mother Teresa", Tirana, Albania.
- Ambulatory Polyclinic of Specialties, Nr. 3, Tirana, Albania.
ORCID-Profile: Julijana Asllani, George Konstantinou, Xenofon Aggelidis
Förderung
- Stallergenes
- European Academy of Allergy and Clinical Immunology
Zitieren
APA
Asllani, J., Mitsias, D., Konstantinou, G., Mesonjesi, E., Xhixha, F., Shehu, E., Christoff, G., Noleva, K., Makris, M., Aggelidis, X., Turkalj, M., Damir, E., Agache, I., Tomic-Spiric, V., Stosovic, R., Misirligil, Z., Kosnik, M., Popov, T. A., Calderon, M., …, & ADER study group (2023). Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies—Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce. Clinical and Translational Allergy, 13(6). https://doi.org/10.1002/clt2.12250
Vancouver
Asllani J, Mitsias D, Konstantinou G, Mesonjesi E, Xhixha F, Shehu E, et al. Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies—Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce. Clinical and Translational Allergy. 2023;13(6). doi:10.1002/clt2.12250
BibTeX
@article{Asllani2023,
author = {Asllani, Julijana and Mitsias, Dimitrios and Konstantinou, George and Mesonjesi, Eris and Xhixha, Fatmira and Shehu, Esmeralda and Christoff, George and Noleva, Katia and Makris, Michael and Aggelidis, Xenofon and Turkalj, Mirjana and Damir, Erceg and Agache, Ioana and Tomic-Spiric, Vesna and Stosovic, Rajica and Misirligil, Zeynep and Kosnik, Mitja and Popov, Todor A and Calderon, Moises and Papadopoulos, Nikolaos G and ADER study group, ADER study group},
title = {Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies—Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce},
journal = {Clinical and Translational Allergy},
year = {2023},
volume = {13},
number = {6},
doi = {10.1002/clt2.12250}
}
EUVIMED